Vince Jensen was named chief clinical operating officer of City of Hope. Jensen will lead clinical operations on City of Hope’s main campus in Los Angeles and throughout its network of more than 35 care locations in Southern California.
Researchers from City of Hope have developed a “plug-and-play” technology that adds engineered molecules to chimeric antigen receptor T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. The preclinical study offers a more flexible way to help CAR T cells keep pace with mutating tumors.
